REGULATED PRESS RELEASE published on 04/26/2024 at 18:00, 2 years 6 months ago DPEF - Rapport annuel 2023
BRIEF published on 04/02/2024 at 18:05, 2 years 7 months ago EXACOMPTA CLAIREFONTAINE annonce de solides résultats financiers pour 2023 Résultats Financiers Dividende Hausse Des Revenus Exacompta Clairefontaine Marché De La Papeterie
BRIEF published on 04/02/2024 at 18:05, 2 years 7 months ago EXACOMPTA CLAIREFONTAINE Reports Strong Financial Results for 2023 Financial Results Revenue Growth Dividend Exacompta Clairefontaine Stationery Market
REGULATED PRESS RELEASE published on 04/02/2024 at 18:00, 2 years 7 months ago Financial statements - 31 december 2023 EXACOMPTA CLAIREFONTAINE reports 2023 financial results with €843.2M revenue and €72.1M operating income. Decline in paper demand in Europe observed. Outlook uncertain with pulp prices rising and energy costs increasing Financial Results Revenue Exacompta Clairefontaine Paper Demand Pulp Prices
BRIEF published on 03/28/2024 at 18:05, 2 years 7 months ago EXACOMPTA CLAIREFONTAINE presents its 2023 financial results and outlook 2023 Results Financial Perspective Exacompta Clairefontaine Paper Sector Stationery Market
BRIEF published on 03/28/2024 at 18:05, 2 years 7 months ago EXACOMPTA CLAIREFONTAINE présente ses résultats financiers 2023 et perspectives Résultats 2023 Perspective Financière Exacompta Clairefontaine Secteur Papier Marché Papeterie
REGULATED PRESS RELEASE published on 03/28/2024 at 18:00, 2 years 7 months ago Arrêté des comptes au 31 décembre 2023 et perspectives Le conseil d'administration d'EXACOMPTA CLAIREFONTAINE a arrêté les comptes au 31 décembre 2023. Analyse des résultats, informations sectorielles, conjoncture, perspectives et résultats financiers du groupe Résultats Financiers Dividende Perspectives Comptes Annuels Exacompta Clairefontaine
BRIEF published on 03/08/2024 at 18:05, 2 years 8 months ago Evolution of voting rights and shares at EXACOMPTA CLAIREFONTAINE in 2023 Voting Rights Actions AMF Exacompta Clairefontaine Evolution 2023
BRIEF published on 03/08/2024 at 18:05, 2 years 8 months ago Evolution des droits de vote et actions chez EXACOMPTA CLAIREFONTAINE en 2023 Droits De Vote Actions AMF Exacompta Clairefontaine Evolution 2023
REGULATED PRESS RELEASE published on 03/08/2024 at 18:00, 2 years 8 months ago Droits de vote et actions 2023 Déclaration des droits de vote et actions de la société EXACOMPTA CLAIREFONTAINE au cours de l'année 2023 selon l'article 223‐16 du Règlement général de l'AMF Droits De Vote Capital Social Actions AMF Exacompta Clairefontaine
Published on 11/06/2026 at 22:15, 2 days 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:30, 22 minutes ago Shelly Group: Invitation to Earnings Webcast/Call on 11 November 2026 on Unaudited 9M 2026 Results
Published on 11/09/2026 at 09:00, 52 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 52 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 52 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 52 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 52 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 52 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 52 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 52 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
